Ken Metchette

2.7k total citations · 1 hit paper
10 papers, 1.4k citations indexed

About

Ken Metchette is a scholar working on Immunology, Oncology and Infectious Diseases. According to data from OpenAlex, Ken Metchette has authored 10 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 4 papers in Oncology and 2 papers in Infectious Diseases. Recurrent topics in Ken Metchette's work include interferon and immune responses (6 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Immunotherapy and Immune Responses (2 papers). Ken Metchette is often cited by papers focused on interferon and immune responses (6 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Immunotherapy and Immune Responses (2 papers). Ken Metchette collaborates with scholars based in United States. Ken Metchette's co-authors include Justin J. Leong, Thomas W. Dubensky, David B. Kanne, Sarah M. McWhirter, Kelsey E. Sivick, Leticia Corrales, Edward E. Lemmens, Laura Hix Glickman, George E. Katibah and Thomas F. Gajewski and has published in prestigious journals such as Blood, Cancer Research and Cell Reports.

In The Last Decade

Ken Metchette

10 papers receiving 1.4k citations

Hit Papers

Direct Activation of STING in the Tumor Microenvironment ... 2015 2026 2018 2022 2015 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity
    2015 1.1k citations Leticia Corrales, Laura Hix Glickman et al. Cell Reports profile →

Peers

Ken Metchette
Arthur E. H. Bentlage Netherlands
Marina Panozzo Italy
Isabelle Magalhaes Sweden
Felix Bohne Germany
L Gemmell United States
Thomas Coyle United States
Chiara Buracchi Italy
Patricia K. A. Mongini United States
Kim C. M. Santegoets Netherlands
Mercedes Porosnicu United States
Arthur E. H. Bentlage Netherlands
Ken Metchette
Citations per year, relative to Ken Metchette Ken Metchette (= 1×) peers Arthur E. H. Bentlage

Countries citing papers authored by Ken Metchette

Since Specialization
Citations

This map shows the geographic impact of Ken Metchette's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Metchette with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Metchette more than expected).

Fields of papers citing papers by Ken Metchette

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken Metchette. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Metchette. The network helps show where Ken Metchette may publish in the future.

Co-authorship network of co-authors of Ken Metchette

This figure shows the co-authorship network connecting the top 25 collaborators of Ken Metchette. A scholar is included among the top collaborators of Ken Metchette based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken Metchette. Ken Metchette is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Deng, Weiwen, Anthony L. Desbien, Gabrielle L. Reiner, et al.. (2020). Abstract PR09: ADU-S100 (MIW815) synergizes with checkpoint blockade to elicit an antitumor CD8+ T-cell response to control distal tumors. Cancer Immunology Research. 8(4_Supplement). PR09–PR09. 4 indexed citations
2.
Corrales, Leticia, Weiwen Deng, Gabrielle L. Reiner, et al.. (2019). Abstract 1202: Tumor cell intrinsic STING signaling demonstrates minimal contribution to the anti-tumor response elicited by the STING agonist ADU-S100 (MIW815). Cancer Research. 79(13_Supplement). 1202–1202. 2 indexed citations
3.
Dis, Erik Van, Kimberly M. Sogi, Chris S. Rae, et al.. (2018). STING-Activating Adjuvants Elicit a Th17 Immune Response and Protect against Mycobacterium tuberculosis Infection. Cell Reports. 23(5). 1435–1447. 91 indexed citations
4.
Corrales, Leticia, Laura Hix Glickman, Sarah M. McWhirter, et al.. (2015). Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity. Cell Reports. 11(7). 1018–1030. 1146 indexed citations breakdown →
5.
Corrales, Leticia, Laura Hix Glickman, Sarah M. McWhirter, et al.. (2014). Direct activation of STING in the tumor microenvironment with synthetic cyclic dinucleotide derivatives leads to potent and systemic tumor-specific immunity. Journal for ImmunoTherapy of Cancer. 2(S3). 2 indexed citations
6.
Dubensky, Thomas W., Meredith L. Leong, David B. Kanne, et al.. (2013). Abstract 4573: STINGVAX - A novel tumor vaccine with cyclic dinucleotides - can induce potent anti-tumor responses in vivo.. Cancer Research. 73(8_Supplement). 4573–4573. 2 indexed citations
7.
Leong, Meredith L., David B. Kanne, Laura Hix Glickman, et al.. (2013). Modified STING-activating cyclic dinucleotide derivatives significantly enhance the anti-tumor activity of therapeutic vaccines. Journal for ImmunoTherapy of Cancer. 1(Suppl 1). O20–O20. 1 indexed citations
8.
Metchette, Ken, et al.. (1998). Inactivation of Leukocytes in Platelet Concentrates by Photochemical Treatment With Psoralen Plus UVA. Blood. 91(6). 2180–2188. 4 indexed citations
9.
Metchette, Ken, et al.. (1998). Inactivation of Leukocytes in Platelet Concentrates by Photochemical Treatment With Psoralen Plus UVA. Blood. 91(6). 2180–2188. 147 indexed citations
10.
Lin, L., Patrizia Damonte, Kent Dupuis, et al.. (1998). Photochemical Treatment of Platelet Concentrates with a Novel Psoralen and UVA to Enhance the Safety of Platelet Transfusions<sub>a</sub>. Transfusion Medicine and Hemotherapy. 25(1). 39–48. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Arthur E. H. Bentlage Breakdown of academic impact, for papers by Marina Panozzo Breakdown of academic impact, for papers by Isabelle Magalhaes Breakdown of academic impact, for papers by Felix Bohne Breakdown of academic impact, for papers by L Gemmell Breakdown of academic impact, for papers by Thomas Coyle Breakdown of academic impact, for papers by Chiara Buracchi Breakdown of academic impact, for papers by Patricia K. A. Mongini Breakdown of academic impact, for papers by Kim C. M. Santegoets Breakdown of academic impact, for papers by Mercedes Porosnicu
Rankless by CCL
2026